Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 6 (MTND4P6) is a segment of DNA classified as a pseudogene, meaning it is a nonfunctional copy or fragment of the mitochondrial ND4 gene, which has lost the ability to encode a functional protein. It neither produces a protein nor contributes to any known biological processes or disease mechanisms, nor is it targeted by therapeutic agents. Pseudogenes such as MTND4P6 are typically considered genomic "fossils" or remnants of evolutionary processes and are not classified as druggable targets[4][7][8]. If your intention was to find information on the functional **MT-ND4** gene or its protein product, that is a distinct and therapeutically relevant mitochondrial enzyme subunit involved in respiratory chain function[1][3][5][9]. This entry is not a therapeutic target and should be excluded from drug-target or biomarker datasets[4][7][8].
None, as this is not an expressed or functional target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 6 (MTND4P6).